Filgotinib shows improvements in rheumatoid arthritis trial - Drug Development Technology

Filgotinib shows improvements in rheumatoid arthritis trial  Drug Development Technology

An international Phase III trial has demonstrated that Gilead's filgotinib led to improvements in rheumatoid arthritis patients.



Comments

Popular posts from this blog

Epstein-Barr virus and autoimmune diseases

Chronic Lyme arthritis: A mystery solved?

Fibromyalgia — Latest Stories — Pain News Network